Prophylactic treatment regimens lead to improvements in health-related quality- of-life (HRQoL) among individuals with...
Read More
In Italy, nucleic acid testing for hepatitis B virus (HBV) in donor screening allows...
The current interest in recombinant factor VIII (rFVIII) products stems from the fact that...
The current plasma collection capacity of several countries will be soon unable to afford...
Adeno-associated virus (AAV)-mediated gene therapy is a promising treatment option for patients with hemophilia...
Discrepancies among several assays results can be observed within the laboratory monitoring of FVIII...
Red Blood Cells (RBC) and whole blood cell transfusions have been reported to decrease...
Hepatitis A virus (HAV) outbreaks are becoming more common in high-income countries with low...
A recently published review has focused on the evolution of treatment landscape of hemophilia...
Platelet transfusions may be ineffective for bleeding prevention in subjects with inherited platelet disorders...